An A1C test is a blood test that reflects your average blood glucose levels over the past 3 months. The A1C test is sometimes called the hemoglobin A1C, HbA1c, glycated hemoglobin, or glycohemoglobin test. Hemoglobin is the part of a red blood cell that carries oxygen to the cells.
Determining glycated hemoglobin levels assure healthcare professionals about the patient’s blood glucose levels. This test is used for diagnosing and monitoring hemoglobin A1c levels in the diabetic patients. As the A1c test reflects the average amount of glucose for the past two to three months, it is considered to be more reliable than traditional blood glucose tests. Due to increasing incidence of diabetes and growing awareness of better management of diabetes, the global hemoglobin A1c testing devices market is expected to develop rapidly in the years to come. Nowadays, medical professionals usually prescribe HbA1c test over conventional blood glucose tests to patients.
In 2018, the global Hemoglobin A1c Monitoring market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hemoglobin A1c Monitoring status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemoglobin A1c Monitoring development in United States, Europe and China.
The key players covered in this study
Bayer Healthcare Diabetes Care (US)
Abbott Laboratories (US)
Roche Diagnostics (Switzerland)
Axis-Shield plc (UK)
Beckman Coulter, Inc. (US)
Bio-Rad Laboratories Inc (US)
Diazyme Laboratories Inc. (US)
EKF Diagnostics Holdings Plc (UK)
HEMOCUE(r) AB (Sweden)
Infopia Co. Ltd. (South Korea)
Menarini Diagnostics Ltd. (UK)
Siemens Healthcare Diagnostics (Germany)
Tosoh Bioscience, Inc (US)
Trinity Biotech plc (Ireland)
ARKRAY, Inc. (Japan)
Market segment by Type, the product can be split into
Ion-exchange
High-performance liquid chromatography (HPLC)
Immunoassay
Boronate affinity chromatography
Direct enzymatic assay
Market segment by Application, split into
HbA1c Laboratory Testing
HbA1c Point of Care Testing
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hemoglobin A1c Monitoring status, future forecast, growth opportunity, key market and key players.
To present the Hemoglobin A1c Monitoring development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hemoglobin A1c Monitoring are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Hemoglobin A1c Monitoring. Industry analysis & Market Report on Hemoglobin A1c Monitoring is a syndicated market report, published as Global Hemoglobin A1c Monitoring Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Hemoglobin A1c Monitoring market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.